Microbot Medical Inc. (MBOT)

Market Cap	147.08M +62.2%
Revenue (ttm)	n/a
Net Income	-13.14M
EPS	-0.29
Shares Out	67.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,452,594
Open	2.140
Previous Close	2.190
Day's Range	2.080 - 2.190
52-Week Range	1.600 - 4.670
Beta	1.06
Analysts	Strong Buy
Price Target	7.50 (+242.47%)
Earnings Date	May 15, 2026

About MBOT

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal reva...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 43
• Stock Exchange: NASDAQ
• Ticker Symbol: MBOT
• Website: https://microbotmedical.com

Analyst Summary

According to 3 analysts, the average rating for MBOT stock is "Strong Buy." The 12-month stock price target is $7.5, which is an increase of 242.47% from the latest price.

Price Target

$7.5

(242.47% upside)

Analyst Consensus: Strong Buy